Connect with us

Health

Study Finds Cycling JAK Inhibitors Effective Option for Patients with Difficult-to-Treat RA – Newswise

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that people…

Published

on

Article feature image

Newswise — ATLANTA — New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that people with difficult-to-treat rheumatoid arthritis who do not have success with one Janus kinase inhibitor (JAK…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending